凤凰网首页 手机凤凰网

凤凰卫视
  • [亚太] 上证指数 2319.12 (1.00%) 深证成指 9466.14 1.78% 恒生指数 19664.10 -1.06% 台北 7233.69 0.17% 韩国 1964.83 0.39%
  • [亚太] 日经 8841.22 -0.09% 澳大利亚 4348.48 0.45% 新西兰 3294.64 0.40% 印度孟买 17234.00 0.92% 新加坡 2916.26 0.75%
  • [美洲] 道琼斯 12660.50 -0.58% 纳斯达克 2816.55 0.40% 标普500 1316.33 -0.16% 加拿大 12466.50 0.02% 巴西 62904.20 -0.08%
  • [欧洲] 英国富时 5733.45 -1.07% 法国CAC 3318.76 -1.32% 德国DAX 6511.98 -0.43% 俄罗斯 1508.04 -0.44% Stoxx50 2436.62 -0.97%
  • [其他] 纽约原油 99.70 0.00% 纽约黄金 1738.40 0.00% 人民币/美元 6.33 0.00% 美元指数 78.83 0.00% 基金指数 3782.30 1.37%
  • [亚太] 上证指数 2319.12 (1.00%) 深证成指 9466.14 1.78% 恒生指数 19664.10 -1.06% 台北 7233.69 0.17% 韩国 1964.83 0.39%
  • [亚太] 日经 8841.22 -0.09% 澳大利亚 4348.48 0.45% 新西兰 3294.64 0.40% 印度孟买 17234.00 0.92% 新加坡 2916.26 0.75%
  • [美洲] 道琼斯 12660.50 -0.58% 纳斯达克 2816.55 0.40% 标普500 1316.33 -0.16% 加拿大 12466.50 0.02% 巴西 62904.20 -0.08%
  • [欧洲] 英国富时 5733.45 -1.07% 法国CAC 3318.76 -1.32% 德国DAX 6511.98 -0.43% 俄罗斯 1508.04 -0.44% Stoxx50 2436.62 -0.97%
  • [其他] 纽约原油 99.70 0.00% 纽约黄金 1738.40 0.00% 人民币/美元 6.33 0.00% 美元指数 78.83 0.00% 基金指数 3782.30 1.37%
免费注册
梅花生物(600873)公告正文

梅花生物:2018年第一季度报告

公告日期 2018-04-27
股票简称:梅花生物 股票代码:600873
                   2018 年第一季度报告



公司代码:600873                         公司简称:梅花生物




    梅花生物科技集团股份有限公司




             2018 年第一季度报告




                         1 / 17
                                 2018 年第一季度报告




                                      目录
一、 重要提示 ................................................................... 3

二、 公司基本情况 ............................................................... 3

三、 重要事项 ................................................................... 5

四、 附录 ....................................................................... 7




                                       2 / 17
                                              2018 年第一季度报告



一、 重要提示

1.1 公司董事会、监事会及董事、监事、高级管理人员保证季度报告内容的真实、准确、完整,
    不存在虚假记载、误导性陈述或者重大遗漏,并承担个别和连带的法律责任。

1.2 公司全体董事出席董事会审议季度报告。

1.3 公司负责人王爱军、主管会计工作负责人王威及会计机构负责人(会计主管人员)王爱玲保
    证季度报告中财务报表的真实、准确、完整。

1.4 本公司第一季度报告未经审计。

二、 公司基本情况

2.1 主要财务数据
                                                                                          单位:元       币种:人民币
                                                                                         本报告期末比上年度末增
                                     本报告期末                     上年度末
                                                                                                      减(%)
总资产                         17,740,409,743.81              17,101,915,003.75                 3.73
归属于上市公司股东的净资产      9,353,082,957.38                9,105,157,993.88                  2.72
                                    年初至报告期末            上年初至上年报告期末           比上年同期增减(%)
经营活动产生的现金流量净额          350,663,734.26                305,550,291.38                  14.76
                                    年初至报告期末            上年初至上年报告期末           比上年同期增减(%)
营业收入                        3,206,676,054.17                2,739,108,531.41                  17.07
归属于上市公司股东的净利润          247,924,963.50                341,433,631.67                 -27.39
归属于上市公司股东的扣除非
                                    212,424,121.71                284,100,338.50                 -25.23
经常性损益的净利润
加权平均净资产收益率(%)              2.69                         3.70                  减少 1.01 个百分点
基本每股收益(元/股)                  0.08                         0.11                         -27.27
稀释每股收益(元/股)                  0.08                         0.11                         -27.27


非经常性损益项目和金额
√适用 □不适用
                                                                                          单位:元       币种:人民币
                             项目                                                 本期金额                    说明
非流动资产处置损益                                                                     -169,750.61
计入当期损益的政府补助,但与公司正常经营业务密切相关,符合
                                                                                      1,863,936.66
国家政策规定、按照一定标准定额或定量持续享受的政府补助除外
委托他人投资或管理资产的损益                                                         10,044,697.97
除同公司正常经营业务相关的有效套期保值业务外,持有交易性金
融资产、交易性金融负债产生的公允价值变动损益,以及处置交易                           29,816,767.34
性金融资产、交易性金融负债和可供出售金融资产取得的投资收益
除上述各项之外的其他营业外收入和支出                                                   -575,999.98
少数股东权益影响额(税后)                                                             -354,255.87
所得税影响额                                                                          -5,124,553.72

                                                     3 / 17
                                             2018 年第一季度报告



                              合计                                                  35,500,841.79



2.2 截止报告期末的股东总数、前十名股东、前十名流通股东(或无限售条件股东)持股情况表
                                                                                                          单位:股
股东总数(户)                                                                                                 165,371
                                             前十名股东持股情况
                              期末持股       比例      持有有限售条         质押或冻结情况
     股东名称(全称)                                                                                    股东性质
                                数量          (%)       件股份数量       股份状态           数量
孟庆山                     854,103,033        27.48                  0     质押          445,190,000    境内自然人
胡继军                     248,469,341         7.99                  0     质押           94,162,000    境内自然人
中国证券金融股份有限公
                           152,285,794         4.90                  0     未知                          国有法人

杨维永                        78,810,526       2.54                  0     无                           境内自然人
王爱军                        71,316,274       2.29                  0     质押           46,000,000    境内自然人
梁宇博                        53,668,518       1.73                  0     质押           24,150,000    境内自然人
梅花生物科技集团股份有
                              34,534,865       1.11                  0     无                              其他
限公司回购专用证券账户
梅花生物科技集团股份有
限公司-2017 年第一期员       29,007,028       0.93                  0     无                              其他
工持股计划
创金合信基金-浦发银行
-创金合信新活力 1 号分       28,831,607       0.93                  0     未知                            其他
级型资产管理计划
何君                          23,449,758       0.75                  0     无                           境内自然人
                                         前十名无限售条件股东持股情况
股东名称                                    持有无限售条件流通股                       股份种类及数量
                                                      的数量                    种类                    数量
孟庆山                                                   854,103,033      人民币普通股                  854,103,033
胡继军                                                   248,469,341      人民币普通股                  248,469,341
中国证券金融股份有限公司                                 152,285,794      人民币普通股                  152,285,794
杨维永                                                    78,810,526      人民币普通股                   78,810,526
王爱军                                                    71,316,274      人民币普通股                   71,316,274
梁宇博                                                    53,668,518      人民币普通股                   53,668,518
梅花生物科技集团股份有限公司回购专
                                                          34,534,865      人民币普通股                   34,534,865
用证券账户
梅花生物科技集团股份有限公司-2017
                                                          29,007,028      人民币普通股                   29,007,028
年第一期员工持股计划
创金合信基金-浦发银行-创金合信新
                                                          28,831,607      人民币普通股                   28,831,607
活力 1 号分级型资产管理计划
何君                                                      23,449,758      人民币普通股                   23,449,758
上述股东关联关系或一致行动的说明            上述股东中,孟庆山、王爱军、何君为一致行动人,其他股东未知其
                                            一致行动关系。



                                                      4 / 17
                                                  2018 年第一季度报告



       2.3 截止报告期末的优先股股东总数、前十名优先股股东、前十名优先股无限售条件股东持股情
           况表

       □适用 √不适用

       三、 重要事项

       3.1 公司主要会计报表项目、财务指标重大变动的情况及原因

       √适用 □不适用

资产负债表:                                                                                                  单位:万元
项目              本报告期末       上年度期末    增减额               增减幅度%    差异说明
预付账款               39,127.80     56,031.28        -16,903.48          -30.17   主要系本期预付材料款减少所致
其他流动资产           54,370.97     22,402.53        31,968.44           142.70   主要系本期公司新增银行理财投资所致
                                                                                   主要系公司子公司新疆梅花在建项目转
在建工程               11,971.88     28,130.98        -16,159.09          -57.44
                                                                                   固所致
                                                                                   主要系公司子公司通辽梅花购进工程物
工程物资                 502.35        249.91               252.44        101.01
                                                                                   资增加所致
                                                                                   本期公司子公司吉林梅花新增土地使用
无形资产           107,085.02        82,387.33        24,697.69            29.98
                                                                                   权所致
                                                                                   主要系公司子公司吉林梅花递延所得税
递延所得税资产          6,008.59      1,254.45            4,754.14        378.98
                                                                                   增加所致
                                                                                   主要系公司子公司吉林梅花预付工程款
其他非流动资产         31,780.45     10,082.33        21,698.12           215.21
                                                                                   增加所致
应付票据                3,150.00      9,500.00            -6,350.00       -66.84   主要系票据到期承付所致
预收款项               21,490.10     31,930.88        -10,440.78          -32.70   主要系上年末公司加大资金回笼所致
应付利息                8,976.36      5,846.94            3,129.42         53.52   主要系公司债应付利息增加所致


利润表:                                                                                                      单位:万元
项目               本报告期         上年同期         增减额           增减幅度%                   差异说明
                                                                                   主要系水资源费改税,本期水资源税在此
税金及附加              5,743.12      4,315.67            1,427.45         33.08
                                                                                   科目核算所致
财务费用                8,370.77      5,842.86            2,527.91         43.26   主要系汇兑损益及利息支出增加所致
公允价值变动损                                                                     主要系本期新增远期结汇业务采用公允
                        1,429.45                          1,429.45        100.00
益                                                                                 价值计量所致
投资收益                2,543.65      1,385.61            1,158.04         83.58   主要系银行理财投资收益增加所致
                                                                                   主要系本期公司子公司通辽梅花政府补
其他收益                 186.39       5,493.89            -5,307.50       -96.61
                                                                                   助减少所致
                                                                                   主要系公司子公司新疆梅花上期保险赔
营业外收入                85.36        344.31              -258.95        -75.21
                                                                                   偿款增加所致
营业外支出               142.96        595.46              -452.50        -75.99   主要系本期捐赠支出减少所致


现金流量表:                                                                                                 单位:万元
项目               本报告期         上年同期         增减额           增减幅度%                   差异说明

                                                           5 / 17
                                           2018 年第一季度报告



经营活动产生的                                                                主要系本期销售收入增加从而销售回款
                  35,066.37   30,555.03     4,511.34                14.76
现金流量净额                                                                  增加,从而经营活动现金收入增加所致
投资活动产生的                                                                主要系公司子公司吉林梅花新增土地使
                 -63,681.16    -9,632.04   -54,049.12              -561.14
现金流量净额                                                                  用权支出增加以及项目支出增加所致
筹资活动产生的                                                                主要系本期银行借款增加以及偿还借款
                  20,674.70   -34,809.38   55,484.08               159.39
现金流量净额                                                                  减少所致



    3.2 重要事项进展情况及其影响和解决方案的分析说明

    √适用 □不适用
         1.2017年第一期员工持股计划执行情况
         经公司 2017 年第一次临时股东大会审议通过,2017 年 1 月 26 日,公司 2017 年第一期员工
    持股计划专户通过二级市场购买方式(竞价交易方式)累计买入梅花生物股票 29,007,028 股,购
    买的梅花生物股票将按照规定予以锁定,锁定期自 2017 年 2 月 4 日起 12 个月。截止本报告出具
    日,2017 年第一期员工持股计划锁定期已满,尚未卖出相关股票。
         2.2017年实施的股份回购事项
         公司于2017年7月13日、2017年11月6日召开的2017年第二次临时股东大会、2017年第四次临
    时股东大会分别审议通过了《关于以集中竞价交易方式回购股份的议案》、《关于调整股份回购
    价格的议案》,自2017年10月30日至2017年11月9日止,公司股份回购专用账户已累计回购股份
    34,534,865股,占公司股本总数的1.11 %(公司股本总数为3,108,226,603股),回购最低价格为5.71
    元/股,回购最高价格为5.90元/股,公司支付的总金额(含佣金、税费)合计人民币19,999.99万元,
    回购的股份用于后续员工持股计划。截止本报告出具日,尚未推出后续计划。
         3.2017年度利润分派进展情况
         公司于2018年3月22日召开了第八届董事会第十三次会议,会议审议通过了《关于2017年度利
    润分配方案(预案)的议案》(具体内容详见2018年3月23日披露在《上海证券报》、《证券时报》
    及上海证券交易所网站的公告),该议案尚需提交年度股东大会审议,股东大会召开时间另行通
    知。

    3.3 报告期内超期未履行完毕的承诺事项

    □适用 √不适用

    3.4 预测年初至下一报告期期末的累计净利润可能为亏损或者与上年同期相比发生重大变动的警
         示及原因说明

    □适用 √不适用
                                                        公司名称             梅花生物科技集团股份有限公司
                                                    法定代表人                           王爱军
                                                          日期                     2018 年 4 月 26 日




                                                  6 / 17
                                        2018 年第一季度报告



四、 附录

4.1 财务报表

                                    合并资产负债表
                                   2018 年 3 月 31 日
编制单位:梅花生物科技集团股份有限公司
                                                           单位:元   币种:人民币   审计类型:未经审计
                  项目                            期末余额                          年初余额
流动资产:
   货币资金                                             2,183,172,776.07               2,277,116,405.54
   结算备付金
   拆出资金
   以公允价值计量且其变动计入当期损益                     27,202,492.34                    7,908,000.00
的金融资产
   衍生金融资产
   应收票据                                               86,735,949.58                  109,191,343.59
   应收账款                                              486,899,888.19                  475,573,438.59
   预付款项                                              391,278,048.33                  560,312,842.25
   应收保费
   应收分保账款
   应收分保合同准备金
   应收利息
   应收股利
   其他应收款                                            147,510,373.86                  142,726,555.99
   买入返售金融资产
   存货                                                 1,212,387,929.66                 995,023,260.79
   持有待售资产
   一年内到期的非流动资产
   其他流动资产                                          543,709,687.53                  224,025,301.93
     流动资产合计                                       5,078,897,145.56               4,791,877,148.68
非流动资产:
   发放贷款和垫款
   可供出售金融资产                                      606,385,354.59                  563,919,754.00
   持有至到期投资
   长期应收款
   长期股权投资                                             9,681,626.17                   9,812,073.15
   投资性房地产
   固定资产                                            10,317,307,652.29              10,359,985,909.93
   在建工程                                              119,718,849.45                  281,309,797.04
   工程物资                                                 5,023,517.04                   2,499,149.11
   固定资产清理
   生产性生物资产

                                              7 / 17
                                        2018 年第一季度报告



   油气资产
   无形资产                                             1,070,850,192.02     823,873,279.30
   开发支出
   商誉                                                  143,173,700.39      143,173,700.39
   长期待摊费用                                           11,481,337.35       12,096,408.99
   递延所得税资产                                         60,085,876.35       12,544,511.15
   其他非流动资产                                        317,804,492.60      100,823,272.01
     非流动资产合计                                    12,661,512,598.25   12,310,037,855.07
       资产总计                                        17,740,409,743.81   17,101,915,003.75
流动负债:
   短期借款                                             3,003,762,000.00    2,768,494,000.00
   向中央银行借款
   吸收存款及同业存放
   拆入资金
   以公允价值计量且其变动计入当期损益
的金融负债
   衍生金融负债
   应付票据                                               31,500,000.00       95,000,000.00
   应付账款                                              586,046,474.50      584,122,790.43
   预收款项                                              214,900,980.35      319,308,817.06
   卖出回购金融资产款
   应付手续费及佣金
   应付职工薪酬                                           67,101,065.64       94,927,531.20
   应交税费                                              189,007,483.07      146,396,845.03
   应付利息                                               89,763,616.62       58,469,367.30
   应付股利                                               12,037,536.00       12,037,536.00
   其他应付款                                            254,383,872.13      213,816,273.70
   应付分保账款
   保险合同准备金
   代理买卖证券款
   代理承销证券款
   持有待售负债
   一年内到期的非流动负债
   其他流动负债
     流动负债合计                                       4,448,503,028.31    4,292,573,160.72
非流动负债:
   长期借款                                              300,000,000.00      300,000,000.00
   应付债券                                             2,992,090,479.97    2,990,994,060.64
   其中:优先股
          永续债
   长期应付款                                             67,720,158.22       67,159,440.60
   长期应付职工薪酬

                                              8 / 17
                                       2018 年第一季度报告



   专项应付款
   预计负债
   递延收益                                             318,274,807.90                     90,791,520.23
   递延所得税负债
   其他非流动负债
     非流动负债合计                                    3,678,085,446.09                  3,448,945,021.47
         负债合计                                      8,126,588,474.40                  7,741,518,182.19
所有者权益
   股本                                                3,108,226,603.00                  3,108,226,603.00
   其他权益工具
   其中:优先股
           永续债
   资本公积                                            2,242,451,490.53                  2,242,451,490.53
   减:库存股                                           199,999,904.37                    199,999,904.37
   其他综合收益
   专项储备
   盈余公积                                             451,082,066.45                    451,082,066.45
   一般风险准备
   未分配利润                                          3,751,322,701.77                  3,503,397,738.27
   归属于母公司所有者权益合计                          9,353,082,957.38                  9,105,157,993.88
   少数股东权益                                         260,738,312.03                    255,238,827.68
     所有者权益合计                                    9,613,821,269.41                  9,360,396,821.56
         负债和所有者权益总计                         17,740,409,743.81                 17,101,915,003.75


法定代表人:王爱军              主管会计工作负责人:王威                     会计机构负责人:王爱玲

                                   母公司资产负债表
                                   2018 年 3 月 31 日
编制单位:梅花生物科技集团股份有限公司
                                                             单位:元   币种:人民币   审计类型:未经审计
                    项目                              期末余额                        年初余额
流动资产:
  货币资金                                                709,892,004.93                  934,732,492.98
  以公允价值计量且其变动计入当期损益的金
融资产
  衍生金融资产
  应收票据                                                   26,400,000.00                 62,210,400.00
  应收账款                                                113,496,685.77                  139,670,497.12
  预付款项                                                   13,060,519.50                130,162,606.64
  应收利息
  应收股利                                                700,000,000.00                  700,000,000.00
  其他应收款                                            2,173,827,040.19                 2,308,966,501.93

                                             9 / 17
                                       2018 年第一季度报告



  存货                                                       56,740,603.39     157,362,533.74
  持有待售资产
  一年内到期的非流动资产
  其他流动资产                                           315,203,602.42         11,552,366.84
   流动资产合计                                         4,108,620,456.20      4,444,657,399.25
非流动资产:
  可供出售金融资产                                       180,919,754.00        180,919,754.00
  持有至到期投资
  长期应收款                                            3,349,204,237.89      3,315,332,818.55
  长期股权投资                                          6,449,575,394.00      6,134,575,394.00
  投资性房地产
  固定资产                                               176,015,867.74        179,739,842.99
  在建工程
  工程物资
  固定资产清理
  生产性生物资产
  油气资产
  无形资产                                               116,580,396.19        122,723,496.88
  开发支出
  商誉
  长期待摊费用                                               11,481,337.35      12,096,408.99
  递延所得税资产                                              1,079,295.43        1,079,295.43
  其他非流动资产
   非流动资产合计                                      10,284,856,282.60      9,946,467,010.84
     资产总计                                          14,393,476,738.80     14,391,124,410.09
流动负债:
  短期借款                                              1,360,000,000.00      1,430,000,000.00
  以公允价值计量且其变动计入当期损益的金
融负债
  衍生金融负债
  应付票据                                                   24,500,000.00      95,000,000.00
  应付账款                                              1,130,871,377.85      1,716,916,306.85
  预收款项                                               108,921,984.33        214,532,020.94
  应付职工薪酬                                                6,593,652.98      12,319,802.77
  应交税费                                                   15,745,744.05        9,409,301.99
  应付利息                                                   84,930,882.88      54,511,385.44
  应付股利                                                   12,037,536.00      12,037,536.00
  其他应付款                                            1,618,071,998.87       831,196,152.55
  持有待售负债
  一年内到期的非流动负债
  其他流动负债
   流动负债合计                                         4,361,673,176.96      4,375,922,506.54

                                             10 / 17
                                   2018 年第一季度报告



非流动负债:
  长期借款                                             300,000,000.00                 300,000,000.00
  应付债券                                          2,992,090,479.97                 2,990,994,060.64
  其中:优先股
         永续债
  长期应付款                                             47,720,158.22                 47,159,440.60
  长期应付职工薪酬
  专项应付款
  预计负债
  递延收益
  递延所得税负债
  其他非流动负债
   非流动负债合计                                   3,339,810,638.19                 3,338,153,501.24
     负债合计                                       7,701,483,815.15                 7,714,076,007.78
所有者权益:
  股本                                              3,108,226,603.00                 3,108,226,603.00
  其他权益工具
  其中:优先股
         永续债
  资本公积                                          2,208,701,622.94                 2,208,701,622.94
  减:库存股                                           199,999,904.37                 199,999,904.37
  其他综合收益
  专项储备
  盈余公积                                             451,082,066.45                 451,082,066.45
  未分配利润                                        1,123,982,535.63                 1,109,038,014.29
   所有者权益合计                                   6,691,992,923.65                 6,677,048,402.31
     负债和所有者权益总计                          14,393,476,738.80                14,391,124,410.09
法定代表人:王爱军          主管会计工作负责人:王威                     会计机构负责人:王爱玲

                                       合并利润表
                                     2018 年 1—3 月
编制单位:梅花生物科技集团股份有限公司
                                                       单位:元    币种:人民币   审计类型:未经审计
                     项目                            本期金额                      上期金额
一、营业总收入                                           3,206,676,054.17            2,739,108,531.41
其中:营业收入                                           3,206,676,054.17            2,739,108,531.41
     利息收入
     已赚保费
     手续费及佣金收入
二、营业总成本                                           2,946,560,976.55            2,398,947,800.37
其中:营业成本                                           2,438,547,426.31            1,948,799,189.30
     利息支出

                                         11 / 17
                                         2018 年第一季度报告



       手续费及佣金支出
       退保金
       赔付支出净额
       提取保险合同准备金净额
       保单红利支出
       分保费用
       税金及附加                                               57,431,205.17    43,156,733.07
       销售费用                                                246,678,595.55   238,826,069.15
       管理费用                                                120,209,934.34   109,737,216.37
       财务费用                                                 83,707,688.73    58,428,592.48
       资产减值损失                                                -13,873.55
  加:公允价值变动收益(损失以“-”号填列)                    14,294,492.34
       投资收益(损失以“-”号填列)                           25,436,525.99    13,856,097.95
       其中:对联营企业和合营企业的投资收益                       -130,446.98
       资产处置收益(损失以“-”号填列)                         -169,750.61      -219,199.46
       汇兑收益(损失以“-”号填列)
       其他收益                                                  1,863,936.66    54,938,909.19
三、营业利润(亏损以“-”号填列)                             301,540,282.00   408,736,538.72
  加:营业外收入                                                  853,552.71      3,443,098.57
  减:营业外支出                                                 1,429,552.69     5,954,582.84
四、利润总额(亏损总额以“-”号填列)                         300,964,282.02   406,225,054.45
  减:所得税费用                                                47,539,834.17    57,495,747.31
五、净利润(净亏损以“-”号填列)                             253,424,447.85   348,729,307.14
  (一)按经营持续性分类                                       253,424,447.85   348,729,307.14
     1.持续经营净利润(净亏损以“-”号填列)                  253,424,447.85   348,729,307.14
     2.终止经营净利润(净亏损以“-”号填列)
  (二)按所有权归属分类                                       253,424,447.85   348,729,307.14
     1.少数股东损益                                              5,499,484.35     7,295,675.47
     2.归属于母公司股东的净利润                                247,924,963.50   341,433,631.67
六、其他综合收益的税后净额
  归属母公司所有者的其他综合收益的税后净额
     (一)以后不能重分类进损益的其他综合收益
       1.重新计量设定受益计划净负债或净资产的变

       2.权益法下在被投资单位不能重分类进损益的
其他综合收益中享有的份额
     (二)以后将重分类进损益的其他综合收益
       1.权益法下在被投资单位以后将重分类进损益
的其他综合收益中享有的份额
       2.可供出售金融资产公允价值变动损益
       3.持有至到期投资重分类为可供出售金融资产
损益

                                                12 / 17
                                         2018 年第一季度报告



      4.现金流量套期损益的有效部分
      5.外币财务报表折算差额
      6.其他
  归属于少数股东的其他综合收益的税后净额
七、综合收益总额                                                253,424,447.85             348,729,307.14
  归属于母公司所有者的综合收益总额                              247,924,963.50             341,433,631.67
  归属于少数股东的综合收益总额                                    5,499,484.35               7,295,675.47
八、每股收益:
  (一)基本每股收益(元/股)                                                0.08                      0.11
  (二)稀释每股收益(元/股)                                                0.08                      0.11
本期发生同一控制下企业合并的,被合并方在合并前实现的净利润为:0 元,上期被合并方实现
的净利润为:0 元。
法定代表人:王爱军        主管会计工作负责人:王威          会计机构负责人:王爱玲

                                     母公司利润表
                                    2018 年 1—3 月
编制单位:梅花生物科技集团股份有限公司
                                                         单位:元      币种:人民币   审计类型:未经审计
                     项目                                 本期金额                      上期金额
一、营业收入                                                   1,963,729,608.95          1,736,489,143.39
  减:营业成本                                                 1,748,028,854.28          1,521,076,163.79
      税金及附加                                                  5,021,799.31               3,475,080.96
      销售费用                                                  160,005,076.68             158,284,895.49
      管理费用                                                   36,194,757.59              31,363,984.87
      财务费用                                                    4,328,349.48               1,135,139.34
      资产减值损失
  加:公允价值变动收益(损失以“-”号填列)
      投资收益(损失以“-”号填列)                              7,125,863.85               8,678,884.01
      其中:对联营企业和合营企业的投资收益
      资产处置收益(损失以“-”号填列)                              -1,784.64                 -5,068.42
      其他收益
二、营业利润(亏损以“-”号填列)                               17,274,850.82              29,827,694.53
  加:营业外收入                                                    449,177.58                379,974.52
  减:营业外支出                                                    142,238.59                  61,200.01
三、利润总额(亏损总额以“-”号填列)                           17,581,789.81              30,146,469.04
    减:所得税费用                                                2,637,268.47
四、净利润(净亏损以“-”号填列)                               14,944,521.34              30,146,469.04
  (一)持续经营净利润(净亏损以“-”号填列)                   14,944,521.34              30,146,469.04
  (二)终止经营净利润(净亏损以“-”号填列)
五、其他综合收益的税后净额
  (一)以后不能重分类进损益的其他综合收益
    1.重新计量设定受益计划净负债或净资产的变动


                                               13 / 17
                                          2018 年第一季度报告



     2.权益法下在被投资单位不能重分类进损益的其
他综合收益中享有的份额
  (二)以后将重分类进损益的其他综合收益
     1.权益法下在被投资单位以后将重分类进损益的
其他综合收益中享有的份额
     2.可供出售金融资产公允价值变动损益
     3.持有至到期投资重分类为可供出售金融资产损

     4.现金流量套期损益的有效部分
     5.外币财务报表折算差额
     6.其他
六、综合收益总额                                                   14,944,521.34               30,146,469.04
七、每股收益:
     (一)基本每股收益(元/股)
     (二)稀释每股收益(元/股)
法定代表人:王爱军               主管会计工作负责人:王威                    会计机构负责人:王爱玲

                                  合并现金流量表
                                    2018 年 1—3 月
编制单位:梅花生物科技集团股份有限公司
                                                               单位:元   币种:人民币   审计类型:未经审计
                     项目                                   本期金额                      上期金额
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金                                3,173,821,192.89              2,691,587,772.04
  客户存款和同业存放款项净增加额
  向中央银行借款净增加额
  向其他金融机构拆入资金净增加额
  收到原保险合同保费取得的现金
  收到再保险业务现金净额
  保户储金及投资款净增加额
  处置以公允价值计量且其变动计入当期损益
的金融资产净增加额
  收取利息、手续费及佣金的现金
  拆入资金净增加额
  回购业务资金净增加额
  收到的税费返还                                                  5,631,869.45
  收到其他与经营活动有关的现金                                    8,640,422.64                 59,032,687.24
     经营活动现金流入小计                                     3,188,093,484.98              2,750,620,459.28
  购买商品、接受劳务支付的现金                                2,091,724,202.02              1,734,747,190.57
  客户贷款及垫款净增加额
  存放中央银行和同业款项净增加额
  支付原保险合同赔付款项的现金


                                                  14 / 17
                                       2018 年第一季度报告



  支付利息、手续费及佣金的现金
  支付保单红利的现金
  支付给职工以及为职工支付的现金                         228,323,434.54               213,660,654.60
  支付的各项税费                                         251,812,064.50               242,859,120.07
  支付其他与经营活动有关的现金                           265,570,049.66               253,803,202.66
    经营活动现金流出小计                               2,837,429,750.72              2,445,070,167.90
      经营活动产生的现金流量净额                         350,663,734.26               305,550,291.38
二、投资活动产生的现金流量:
  收回投资收到的现金                                         68,900,000.00             17,000,000.00
  取得投资收益收到的现金                                     25,600,784.00             13,857,015.86
  处置固定资产、无形资产和其他长期资产收回                      45,000.00                 150,000.00
的现金净额
  处置子公司及其他营业单位收到的现金净额                                              300,000,000.00
  收到其他与投资活动有关的现金                           228,571,072.85
    投资活动现金流入小计                                 323,116,856.85               331,007,015.86
  购建固定资产、无形资产和其他长期资产支付               567,890,480.34                63,727,389.89
的现金
  投资支付的现金                                         392,037,964.02               363,600,000.00
  质押贷款净增加额
  取得子公司及其他营业单位支付的现金净额
  支付其他与投资活动有关的现金
    投资活动现金流出小计                                 959,928,444.36               427,327,389.89
      投资活动产生的现金流量净额                        -636,811,587.51                -96,320,374.03
三、筹资活动产生的现金流量:
  吸收投资收到的现金
  其中:子公司吸收少数股东投资收到的现金
  取得借款收到的现金                                   1,299,190,000.00               963,670,000.00
  发行债券收到的现金
  收到其他与筹资活动有关的现金                               26,016,707.20
    筹资活动现金流入小计                               1,325,206,707.20               963,670,000.00
  偿还债务支付的现金                                   1,059,000,000.00              1,268,556,000.00
  分配股利、利润或偿付利息支付的现金                         33,525,249.44             40,043,584.10
  其中:子公司支付给少数股东的股利、利润
  支付其他与筹资活动有关的现金                               25,934,417.41              3,164,188.25
    筹资活动现金流出小计                               1,118,459,666.85              1,311,763,772.35
      筹资活动产生的现金流量净额                         206,747,040.35              -348,093,772.35
四、汇率变动对现金及现金等价物的影响                     -14,460,526.78                 -1,745,374.69
五、现金及现金等价物净增加额                             -93,861,339.68              -140,609,229.69
  加:期初现金及现金等价物余额                         2,251,099,698.34              2,402,880,986.97
六、期末现金及现金等价物余额                           2,157,238,358.66              2,262,271,757.28
法定代表人:王爱军               主管会计工作负责人:王威                会计机构负责人:王爱玲


                                             15 / 17
                                       2018 年第一季度报告



                                  母公司现金流量表
                                    2018 年 1—3 月
编制单位:梅花生物科技集团股份有限公司
                                                          单位:元   币种:人民币   审计类型:未经审计
                   项目                                本期金额                      上期金额
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金                           1,959,349,211.21               1,645,111,913.92
  收到的税费返还
  收到其他与经营活动有关的现金                           1,690,434,913.97               1,519,899,298.10
    经营活动现金流入小计                                 3,649,784,125.18               3,165,011,212.02
  购买商品、接受劳务支付的现金                           1,764,333,805.94               2,251,487,541.48
  支付给职工以及为职工支付的现金                             27,147,297.19                23,859,371.61
  支付的各项税费                                             26,702,724.29                41,560,005.68
  支付其他与经营活动有关的现金                           1,313,729,315.08               1,575,713,901.72
    经营活动现金流出小计                                 3,131,913,142.50               3,892,620,820.49
      经营活动产生的现金流量净额                           517,870,982.68               -727,609,608.47
二、投资活动产生的现金流量:
  收回投资收到的现金
  取得投资收益收到的现金                                      7,125,863.85              1,008,678,884.01
  处置固定资产、无形资产和其他长期资产收回
的现金净额
  处置子公司及其他营业单位收到的现金净额
  收到其他与投资活动有关的现金
    投资活动现金流入小计                                      7,125,863.85              1,008,678,884.01
  购建固定资产、无形资产和其他长期资产支付                    5,323,940.00                      7,300.00
的现金
  投资支付的现金                                           615,000,000.00
  取得子公司及其他营业单位支付的现金净额
  支付其他与投资活动有关的现金
    投资活动现金流出小计                                   620,323,940.00                       7,300.00
      投资活动产生的现金流量净额                          -613,198,076.15               1,008,671,584.01
三、筹资活动产生的现金流量:
  吸收投资收到的现金
  取得借款收到的现金                                       400,000,000.00                570,000,000.00
  收到其他与筹资活动有关的现金                             228,316,707.20                278,000,000.00
    筹资活动现金流入小计                                   628,316,707.20                848,000,000.00
  偿还债务支付的现金                                       470,000,000.00               1,000,000,000.00
  分配股利、利润或偿付利息支付的现金                         23,813,392.96                37,598,927.66
  支付其他与筹资活动有关的现金                             238,000,000.00                    468,212.74
    筹资活动现金流出小计                                   731,813,392.96               1,038,067,140.40
      筹资活动产生的现金流量净额                          -103,496,685.76               -190,067,140.40
四、汇率变动对现金及现金等价物的影响                                 -1.62                         -0.24

                                             16 / 17
                                      2018 年第一季度报告



五、现金及现金等价物净增加额                           -198,823,780.85             90,994,834.90
 加:期初现金及现金等价物余额                           908,715,785.78           1,071,648,834.22
六、期末现金及现金等价物余额                            709,892,004.93           1,162,643,669.12
法定代表人:王爱军              主管会计工作负责人:王威             会计机构负责人:王爱玲


4.2 审计报告

□适用 √不适用




                                            17 / 17
数据加载中...
prevnext
手机查看股票